Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 14334

AbstractCase ReportDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Case report
Year : 2022 | Month : March | Volume : 16 | Issue : 3 | Page : QD01 - QD04 Full Version

Massive Haemoperitoneum Postovulation: A Rare Complication of Unmonitored Anticoagulant Therapy


Published: March 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/50491.16046
Ketav Samir Joshi, Neema Sourya Acharya, Sourya Acharya, Samir Vinod Joshi

1. Resident Doctor, Department of Obstetrics and Gynaecology, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India. 2. Professor and Head, Department of Obstetrics and Gynaecology, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India. 3. Professor and Head, Department of Obstetrics and Gynaecology, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India. 4. Consultant, Department of Obstetrics and Gynaecology, Vinod Joshi Maternity Nursing Home, Mumbai, Maharashtra, India.

Correspondence Address :
Neema Sourya Acharya,
Professor and Head, Department of Obstetrics and Gynaecology, AVBRH, Sawangi (Meghe), Wardha-44217, Maharashtra, India.
E-mail: neemasacharya@gmail.com

Abstract

Derangements in coagulation profile due to ongoing anticoagulant medication can complicate the most primitive physiology in a woman, ovulation. Unmonitored anticoagulant therapy can lead to an array of complications, one of which is intraperitoneal haemorrhage secondary to numerous medical and surgical conditions. The resultant haemoperitoneum can cause sudden hypovolemic shock, especially in a patient with compromised cardiovascular status. This report narrates the case of a 30-years-old nulliparous female patient on anticoagulant therapy, operated for multiple cardiac defects and developed massive haemoperitoneum as a consequence of ovulation. The patient presented in shock to the Emergency Department with unstable haemodynamic status. A multi-disciplinary approach to the case converged on ruptured functional ovarian cyst as a working diagnosis. Conservative management of haemoperitoneum was decided upon, whereby correcting shock and providing pro-coagulant therapy along with blood products was the main line of management. All efforts failed soon after when the cyst wall ruptured catastrophically, leading to collapse of the general condition of the patient. Surgical approach was undertaken and a ruptured ovarian cyst wall was identified to be the cause. The cyst wall was subsequently repaired electrosurgically and the patient recovered well with an uneventful postoperative period. However, the characteristic feature of this case is the lack of follow-up due to lockdown restrictions of this continuum, the Coronavirus Disease-2019 (COVID-19) pandemic. The management of such cases must be carefully titrated, keeping in mind the risks and benefits of both pro-coagulant and anti-coagulant therapy wherein one can jeopardise the effects of the other.

Keywords

Corpus luteal cyst, Intraperitoneal haemorrhage, Warfarin

Case Report

This is the case of a 30-year-old unmarried nulliparous female patient presented to the Gynaecological Emergency unit with complaints of palpitations, breathlessness and pain in abdomen for three days with menorrhagia for the last two cycles. The patient complained of dull abdominal ache for two months that gradually progressed to persistent, severe abdominal pain in the last three days, worsened with movement and change in decubitus. The patient was a known case of rheumatic heart disease with severe mitral stenosis, severe tricuspid stenosis with superimposed tricuspid regurgitation and pulmonary hypertension. The patient had undergone mitral valve replacement with tricuspid annuloplasty 12 years ago and started on anticoagulant medication- oral warfarin (4 mg/day on alternate days), lasix-spironolactone (20-50 mg twice daily), diltiazem (90 mg daily), digoxin (0.25 mg daily). She gave history of stroke and right sided hemiplegia with seventh cranial nerve palsy a year ago and recovered well from the episode. Her last menstrual period was 16 days before presentation with regular 30-day cycles. She did not complain of fever or bleeding from any natural orifices and history of congenital and familial bleeding disorders was unremarkable.

On examination, her Body Mass Index (BMI) was 22.4 kg/m2, Blood Pressure (BP) was 90/60 mmHg, pulse rate 126 beats/min, Partial Oxygen Saturation (SpO2) 98% on room air, raised jugular venous pressure of 8 cm H2O with normal respiratory examination. Her abdomen examination revealed abdominal distension with marked tenderness in left iliac fossa and hypogastrium and per vaginal examination showed tenderness in all fornices. Her haemoglobin was 5.3 gm%, White Blood Cells (WBC) 9900 cells/dL, platelets 1,86,000 cells/dL and haematocrit 15.2%. Prothrombin Time (PT) was 55.8 s with an International Normalised Ratio (INR) 4.46 and a Partial Thromboplastin Time (PTT) 57 s. Pregnancy was subsequently ruled out by urine pregnancy test and β-Human Chorionic Gonadotropin (HCG) level <2.39 mIU/mL. Liver and renal function tests were within normal limits and Cancer Antigen (CA)-125 levels showed 364 U/mL. Both direct and indirect Coomb’s tests were negative. Haemoglobin (Hb) electrophoresis for sickle cell disease was also negative. Ultrasound of the abdomen was suggestive of a complex ovarian cyst on left side measuring approx. 84×72 mm with mild ascites haemoperitoneum (Table/Fig 1). A two-dimensional (2D)-echocardiography revealed dilated atria, severe tricuspid regurgitation, severe pulmonary artery hypertension with 60% ejection fraction (Table/Fig 2).

Ectopic pregnancy was ruled out with a negative urine pregnancy test. Above findings were suggestive of a functional ovarian cyst rupture with mild haemoperitoneum secondary to anticoagulant therapy. Investigations undertaken by the patient seven months ago showed a normal coagulation profile.

A multidisciplinary team of physicians, cardiac surgeons and gynaecologists decided upon a conservative line of management since the general condition of the patient did not necessitate the need for surgical exploration. Anticoagulants were tapered down in consultation with the cardiothoracic surgery team. Tranexamic acid formed the mainstay of management. Tranexamic acid (3 g/day IV in divided doses) was started and three units of Packed Red Cell (PRC) units and 7 units of Fresh Frozen Plasma (FFP) were transfused and the patient gradually showed improvement. However, on day three of admission, she had an episode of syncope with feeble pulse, tachycardia with 160 beats/min and hypotension 80/40 mmHg. An emergency exploratory laparotomy was undertaken.

Exploratory laparotomy revealed approx. 1300 mL of haemoperitoneum including approximately 250 g of clots. Left sided ruptured ovarian cyst was identified with active bleeding from cyst wall and ovarian tissues appeared normal on both sides (Table/Fig 3). The cyst wall was excised electrosurgically (Table/Fig 4). Visceral organs were examined intraoperatively and there was no evidence of bleeding, endometriosis or adhesions. Urogenital and peritoneal surfaces appeared unremarkable. Two units PRC and four units Fresh Frozen Plasma (FFP) were transfused intraoperatively. The aim of the surgery was to identify and control the source of bleeding and to drain the haemoperitoneum. Conservation of fertility was paramount to the patient and formed the core of management despite surgical methods being implemented to control the bleeding. Ruptured corpus luteal cyst was a retrospective diagnosis but the aetiology was ovulation with defective coagulation.

Histopathological examination of the incisional biopsy revealed an otherwise unremarkable corpus luteal cyst wall (Table/Fig 5). The section from the cyst wall tissue was stained with Haematoxylin and Eosin (H&E) and examination under 100x magnification showed the luteal cyst wall containing a well-organised thrombus with areas of red blood cells, surrounding fibrin accumulations, and scattered leucocytes.

She was discharged on Oral Contraceptives (OC) (0.03 mg ethinyl oestradiol with 0.15 mg levonorgestrel) for three months to suppress ovulation. Coagulation profile was advised after 15 days, followed by monthly till therapeutically acceptable INR of 1.5 after which three monthly monitoring was to be undertaken. The couple was counselled on family planning and pre-conceptional dose modification.

Discussion

As the case unfolded, it became clear that the patient was unmonitored on oral anticoagulants due to the ongoing pandemic and rupture of a corpus luteal cyst produced catastrophic haemoperitoneum in the patient. Normally, women may present with ‘mittelschmerz’, characterised by abdominal-pelvic pain during ovulation due to rupture of a mature follicle with subsequent bleeding into the peritoneal cavity (1).

At the time of ovulation, in a patient with defective haemostasis, blood fills in the ruptured follicle to form corpus haemorrhagicum. This collection eventually bleeds into the peritoneal cavity forming haemoperitoneum causing persistent peritoneal irritation or sometimes directly into the broad ligament forming a retroperitoneal haematoma (2). But it was ruled out due to the complex loculated appearance on ultrasound and appearance of symptoms (3). A clinically differentiating factor is that haemoperitoneum primarily due to a ruptured corpus luteum occurs closer to ovulation as compared to postovulatory presentation of a corpus haemorrhagicum (4). It was critical to rule out ectopic pregnancy by β-HCG levels as ruptured ectopic pregnancy has a similar presentation (5).

Non Steroidal Anti-inflammatory Drugs are the preferred analgesics but they must be used cautiously due to their anti-platelet activity. Alternatives like opioids then form the analgesics of choice in these patients (6). A compilation of cases of ruptured functional ovarian cysts is as given in (Table/Fig 6) (1),(2),(3),(5),(7),(8),(9).

In haemodynamically stable patients, haemostatic therapy can be initiated, comprising primarily of oral tranexamic acid (upto 4 g/day in divided doses). Oral tranexamic acid is usually well tolerated and can often be administered in a synergistic combination with oral hormonal therapy (10). Newer treatment modalities including Plasma Cell Concentrates (PCC) and Recombinant Activated Factor VIIa (rFVIIa) are available but lack of substantial evidence and high cost were deterrents in the present case (9). In women on anticoagulants, a ruptured corpus luteal cyst with haemoperitoneum is fatal in 3-11% and can recur in nearly 25-31% of the cases. There is a substantial risk of haemorrhage in patients with an INR of 3.0-4.5 and increases exponentially for values >4.5 (11).

Oral Contraceptives (OCs) are the mainstay of treatment for patients with defective haemostasis. OCs suppresses ovulation and subsequent formation of corpus luteum to prevent similar events in future (12). OC regulate endometrial growth and control shedding, thereby reducing dysmenorrhoea and other menstrual complaints. Long-term OCs obviate the use of blood products and their associated complications during conservative management of such episodes. Blood products also carry a risk of transmission of Human Immunodeficiency Virus (HIV) and hepatitis viruses, though these complications are extremely rare with the advancements in screening and processing of blood products. Conception must be preceded by suspension of OCs with serial follicular ultrasound studies with thorough, multidisciplinary evaluation of anticoagulant therapy during antepartum and peripartum period. Complications at the time of delivery can be managed by blood products and supportive therapy (3),(11).

Newer generation intrauterine contraceptive systems containing levonorgestrel (LNG-IUS) retain efficacy upto seven years and are effective alternatives to OCs (13). They function by curtailing endometrial proliferation and subsequently decrease menstrual blood loss and pain. LNG-IUS is relatively inert to menstrual irregularities and also provides easy reversibility of fertility (14). Gonadotropin-releasing hormone (GnRH) analogues such as leuprolide acetate and goserelin injected subcutaneously offer similar efficacy in suppressing ovulation and menstrual complaints. However, their use is limited by their hypoestrogenic side effects such as hot flashes and reduced bone density, coupled with high cost for long-term therapy. Surgical line of management must be undertaken only with the aid of advanced laboratory support and an experienced haematologist. In cases like these, every effort to preserve fertility must be taken using a combination of conservative surgery, high-dose hormonal therapy with haemostatic drugs (10).

Careful history, examination and plan of action must be well documented and explaining follow-up of investigations and medications is paramount to long-term management of the patient. A system of follow-up of high-risk cases must be developed to prevent such recurrences.

Conclusion

Anticoagulant and anti-platelet medications need stringent follow-up and the patients must be informed in detail, the duration and dosage of medication. Contraceptive therapy must be individualised for every couple after considering desire to conceive in the future. Surgical line of management must be undertaken cautiously weighing the benefits and all short- and long-term complications for the patient.

References

1.
Cetinkaya SE, Pabuccu EG, Ozmen B, Dokmeci F. Recurrent massive hemoperitoneum due to ovulation as a clinical sign in congenital afibrinogenemia. Acta Obstet Gynecol Scand. 2011;90(2):192-94. [crossref] [PubMed]
2.
Payne JH, Maclean RM, Hampton KK, Baxter AJ, Makris M. Haemoperitoneum associated with ovulation in women with bleeding disorders: The case for conservative management and the role of the contraceptive pill. Haemoph Off J World Fed Hemoph. 2007;13(1):93-97. [crossref] [PubMed]
3.
Bottini E, Pareti FI, Mari D, Mannucci PM, Muggiasca ML, Conti M. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports. Haematologica. 1991;76(5):431-33.
4.
Girolami A, Lombardi AM, Candeo N, Scarparo P, Paternoster A. Control of ovulation-induced hemoperitoneum by oral contraceptives in a patient with congenital hypoprothrombinemia and in another with congenital factor V deficiency. Acta Haematol. 2008;119(4):236-40. [crossref] [PubMed]
5.
Agarwal M, Prybot JE, Dhirasaria A. Ruptured corpus luteum cyst in women on anticoagulant: Conservative or surgical management a clinical dilemma. Int J Reprod Contracept Obstet Gynecol. 2017;6(11):5164-65. [crossref]
6.
Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995;35(3):209-19. [crossref] [PubMed]
7.
Özdemir S. A Rare complication of anticoagulant use: Colonic intramural hematoma-case report. Turk J Colorectal Dis. 2019;29:204-05. Doi: 10.4274/tjcd.galenos.2019.2019-7-3. [crossref]
8.
Sikka P, Joshi B, Aggarwal N, Suri V. Corpus luteal hemorrhage in coagulopathy; a case report with review of treatment modalities. [Internet]. Available from: https://austinpublishinggroup.com/obstetrics-gynecology/fulltext/ajog-v2-id1038.php.
9.
Ara A, Malik R, Malla VG. Haemoperitoneum due to ruptured corpus luteum! managed conservatively-2 case reports and review of literature. Int J Reprod Contracept Obstet Gynecol. 2016;5(10):3622-25. [crossref]
10.
Kadir R. WFH eLearning Platform - Reproductive Health in Women with Bleeding Disorders [Internet]. [cited 2021 May 9]. Available from: https://elearning.wfh.org/resource/reproductive-health-in-women-with-bleeding-disorders/.
11.
Gupta A, Gupta S, Manaktala U, Gupta MM, Solanki V. Conservative management of corpus luteum haemorrhage in patients on anticoagulation: A report of three cases and review of literature. Arch Gynecol Obstet. 2015;291(2):427-31. [crossref] [PubMed]
12.
Castaman G, Ruggeri M, Rodeghiero F. Congenital afibrinogenemia: Successful prevention of recurrent hemoperitoneum during ovulation by oral contraceptive. Am J Hematol. 1995;49(4):363-64. [crossref] [PubMed]
13.
Sivin I, Stern J, Coutinho E, Mattos CE, el Mahgoub S, Diaz S, et al. Prolonged intrauterine contraception: A seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception. 1991;44(5):473-80. [crossref]
14.
Kailasam C, Cahill D. Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system. Patient Prefer Adherence. 2008;2:293-302. Doi: 10.2147/ppa.s3464. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/50491.16046

Date of Submission: May 23, 2021
Date of Peer Review: Sep 16, 2021
Date of Acceptance: Dec 01, 2021
Date of Publishing: Mar 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: May 24, 2021
• Manual Googling: Nov 16, 2021
• iThenticate Software: Jan 11, 2022 (9%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com